Tirzepatide Clinics in Nashville, Tennessee

About Tirzepatide

Tirzepatide is the active ingredient in Mounjaro (for type 2 diabetes) and Zepbound (for weight loss). It is the first medication that targets two hunger hormones at once: GIP and GLP-1. By activating both, it produces stronger weight loss and blood sugar control than older GLP-1-only medications like semaglutide. In the largest clinical trial, people on the highest dose lost an average of 22.5% of their body weight, more than any other FDA-approved weight loss drug.

Expected Weight Loss

In the main weight loss trial, people on tirzepatide 15 mg lost an average of 22.5% of their body weight over 72 weeks (about 17 months). At 10 mg, the average was 21.4%. Over a third of people on the highest dose lost 25% or more. For a 200-pound person, 22.5% is roughly 45 pounds.

Cost

Without insurance, Tirzepatide typically costs $1,000-$1,200/month (Mounjaro), $1,000-$1,100/month (Zepbound). With insurance, costs range from $25-$200/month (varies by plan).